ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
0.00%
US Tech 100
16,927.60
-0.33%
S&P 500
5,018.39
-0.34%
US Dollar vs CAD
1.3732
-0.33%
Bitcoin
57,940.36
-4.39%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Theravance Biopharma Inc (TBPH)

  7. Theravance Biopharma Inc (TBPH) News

TBPH Theravance Biopharma Inc

8.84
0.40 (4.74%)
After Hours
Last Updated: 16:53:17
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Theravance Biopharma Inc TBPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.40 4.74% 8.84 16:53:17
Open Price Low Price High Price Close Price Previous Close
8.44 8.40 8.98 8.84 8.44
more quote information »

Recent News

Date Time Source Heading
4/29/202405:00PRNUSTheravance Biopharma to Report First Quarter 2024 Financial..
4/10/202405:00PRNUSTheravance Biopharma, Inc. to Host Virtual Key Opinion..
2/26/202415:16EDGAR2Form 8-K - Current report
2/26/202415:05PRNUSTheravance Biopharma, Inc. Reports Fourth Quarter and Full..
2/22/202419:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202405:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
2/16/202419:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/14/202405:00PRNUSTheravance Biopharma to Report Fourth Quarter and Full Year..
1/16/202405:16EDGAR2Form 8-K - Current report
1/05/202405:07EDGAR2Form 8-K - Current report
1/05/202405:00PRNUSTheravance Biopharma Announces Results from the Phase 4..
12/28/202305:01EDGAR2Form 8-K - Current report
12/26/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/26/202317:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/21/202316:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/21/202316:06EDGAR2Form 8-K - Current report
12/21/202316:00PRNUSTheravance Biopharma, Inc. Announces Appointment of Jeremy..
12/18/202305:00PRNUSTheravance Biopharma to Conduct Investor Meetings During the..
11/22/202317:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202305:00PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
11/15/202305:00PRNUSTheravance Biopharma to Participate in the 6th Annual..
11/13/202307:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
11/09/202315:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202315:53EDGAR2Form 8-K - Current report
11/07/202315:28PRNUSTheravance Biopharma, Inc. Reports Third Quarter 2023..
11/01/202317:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/30/202316:15EDGAR2Form 8-K - Current report
10/19/202305:00PRNUSTheravance Biopharma to Report Third Quarter 2023 Financial..
10/18/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/16/202315:13EDGAR2Form 144 - Report of proposed sale of securities
9/18/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202315:24EDGAR2Form 144 - Report of proposed sale of securities
9/12/202305:05EDGAR2Form 8-K - Current report
8/29/202305:00PRNUSTheravance Biopharma to Participate in an Upcoming Investor..
8/28/202305:05PRNUSTheravance Biopharma to Present New Ampreloxetine Data at..
8/24/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202317:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202317:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/22/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
TBPH
Theravance Biopharma
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved